Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease

Abstract

Intensive lipid-lowering therapy with 80 mg of atorvastatin per day in patients with stable CHD provides significant clinical benefit beyond that afforded by treatment with 10 mg of atorvastatin per day. This occurred with a greater incidence of elevated aminotransferase levels.

Keywords

AtorvastatinMedicineLiterMyocardial infarctionClinical endpointInternal medicineCholesterolCoronary heart diseaseIncidence (geometry)GastroenterologyCardiologyRandomized controlled trial

Affiliated Institutions

Related Publications

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial

Peter Sever , Björn Dahlöf , Neil R Poulter +11 more

The lowering of cholesterol concentrations in individuals at high risk of cardiovascular disease improves outcome. No study, however, has assessed benefits of cholesterol loweri...

2003 The Lancet 3773 citations

High-Dose Atorvastatin after Stroke or Transient Ischemic Attack

Pierre Amarenco , Julien Bogousslavsky , Alfred Callahan +8 more

In patients with recent stroke or TIA and without known coronary heart disease, 80 mg of atorvastatin per day reduced the overall incidence of strokes and of cardiovascular even...

2006 New England Journal of Medicine 2823 citations

Effects of Atorvastatin on Early Recurrent Ischemic Events in Acute Coronary Syndromes<SUBTITLE>The MIRACL Study: A Randomized Controlled Trial</SUBTITLE>

Gregory G. Schwartz

For patients with acute coronary syndrome, lipid-lowering therapy with atorvastatin, 80 mg/d, reduces recurrent ischemic events in the first 16 weeks, mostly recurrent symptomat...

2001 JAMA 2464 citations

Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia

Tom Sjöblom , Esko A. Nikkilä , M. H. Frick +16 more

In a randomized, double-blind five-year trial, we tested the efficacy of simultaneously elevating serum levels of high-density lipoprotein (HDL) cholesterol and lowering levels ...

1987 New England Journal of Medicine 3872 citations

Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease

Salim Yusuf , Eva Lonn , Prem Pais +29 more

BACKGROUND: Elevated blood pressure and elevated low-density lipoprotein (LDL) cholesterol increase the risk of cardiovascular disease. Lowering both should reduce the risk of c...

2016 New England Journal of Medicine 367 citations

Publication Info

Year: 2005
Type: article
Volume: 352
Issue: 14
Pages: 1425-1435
Citations: 3460
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

3460

OpenAlex

Cite This

APA Style

                            
                                
                                    John C. LaRosa, 
                                
                                    Scott M. Grundy, 
                                
                                    David D. Waters
                                
                                et al.
                            
                            (2005). 
                            Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease. 
                            New England Journal of Medicine
                            , 352
                            (14)
                            , 1425-1435.
                            https://doi.org/10.1056/nejmoa050461
                        

Identifiers

DOI: 10.1056/nejmoa050461